Guo Zheng International: Maintains a "buy" rating on Beautiful Countryside Medical Health (02373.HK) with a target price of HKD 45.

According to the latest report from Guotai Junan International, they have maintained their financial forecast for Beautiful Rural Medical Health (02373.HK). It is expected that the company's revenue for the years 2025-2027 will be 3.05 billion yuan, 3.41 billion yuan, and 3.76 billion yuan respectively, with net profit attributable to shareholders of 320 million yuan, 380 million yuan, and 440 million yuan respectively. Based on the valuation levels of two terminal healthcare consumer stocks, Yonghe Medical (02279.HK) and Gushengtang (02273), the company is given a 30xPE for 2025, corresponding to a target price of 45 Hong Kong dollars (previously 19.6 Hong Kong dollars), and has maintained a "buy" rating.